List of Tables
Table 1. Global Treatment Drug of Painful Diabetic Neuropathy Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Treatment Drug of Painful Diabetic Neuropathy Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Treatment Drug of Painful Diabetic Neuropathy Market Competitive Situation by Manufacturers in 2025
Table 4. Global Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Treatment Drug of Painful Diabetic Neuropathy Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Treatment Drug of Painful Diabetic Neuropathy Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Treatment Drug of Painful Diabetic Neuropathy Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Treatment Drug of Painful Diabetic Neuropathy Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Treatment Drug of Painful Diabetic Neuropathy, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Treatment Drug of Painful Diabetic Neuropathy, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Treatment Drug of Painful Diabetic Neuropathy, Product Types and Applications
Table 12. Global Key Manufacturers of Treatment Drug of Painful Diabetic Neuropathy, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Treatment Drug of Painful Diabetic Neuropathy Companies by Tier (Tier 1, Tier 2, Tier 3), based on Treatment Drug of Painful Diabetic Neuropathy Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Treatment Drug of Painful Diabetic Neuropathy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Treatment Drug of Painful Diabetic Neuropathy Sales by Region (K Dose), 2021–2026
Table 18. Global Treatment Drug of Painful Diabetic Neuropathy Sales Market Share by Region (2021–2026)
Table 19. Global Treatment Drug of Painful Diabetic Neuropathy Sales by Region (K Dose), 2027–2032
Table 20. Global Treatment Drug of Painful Diabetic Neuropathy Sales Market Share by Region (2027–2032)
Table 21. Global Treatment Drug of Painful Diabetic Neuropathy Revenue by Region (US$ Million), 2021–2026
Table 22. Global Treatment Drug of Painful Diabetic Neuropathy Revenue Market Share by Region (2021–2026)
Table 23. Global Treatment Drug of Painful Diabetic Neuropathy Revenue by Region (US$ Million), 2027–2032
Table 24. Global Treatment Drug of Painful Diabetic Neuropathy Revenue Market Share by Region (2027–2032)
Table 25. North America Treatment Drug of Painful Diabetic Neuropathy Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Treatment Drug of Painful Diabetic Neuropathy Sales by Country (K Dose), 2021–2026
Table 27. North America Treatment Drug of Painful Diabetic Neuropathy Sales by Country (K Dose), 2027–2032
Table 28. North America Treatment Drug of Painful Diabetic Neuropathy Revenue by Country (US$ Million), 2021–2026
Table 29. North America Treatment Drug of Painful Diabetic Neuropathy Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Treatment Drug of Painful Diabetic Neuropathy Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Treatment Drug of Painful Diabetic Neuropathy Sales by Country (K Dose), 2021–2026
Table 32. Europe Treatment Drug of Painful Diabetic Neuropathy Sales by Country (K Dose), 2027–2032
Table 33. Europe Treatment Drug of Painful Diabetic Neuropathy Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Treatment Drug of Painful Diabetic Neuropathy Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Treatment Drug of Painful Diabetic Neuropathy Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Treatment Drug of Painful Diabetic Neuropathy Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Treatment Drug of Painful Diabetic Neuropathy Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Treatment Drug of Painful Diabetic Neuropathy Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Treatment Drug of Painful Diabetic Neuropathy Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Treatment Drug of Painful Diabetic Neuropathy Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Treatment Drug of Painful Diabetic Neuropathy Sales by Country (K Dose), 2021–2026
Table 42. Latin America Treatment Drug of Painful Diabetic Neuropathy Sales by Country (K Dose), 2027–2032
Table 43. Latin America Treatment Drug of Painful Diabetic Neuropathy Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Treatment Drug of Painful Diabetic Neuropathy Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Treatment Drug of Painful Diabetic Neuropathy Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Treatment Drug of Painful Diabetic Neuropathy Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Treatment Drug of Painful Diabetic Neuropathy Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Treatment Drug of Painful Diabetic Neuropathy Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Treatment Drug of Painful Diabetic Neuropathy Revenue by Country (US$ Million), 2027–2032
Table 50. Global Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose) by Type (2021–2026)
Table 51. Global Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose) by Type (2027–2032)
Table 52. Global Treatment Drug of Painful Diabetic Neuropathy Sales Market Share by Type (2021–2026)
Table 53. Global Treatment Drug of Painful Diabetic Neuropathy Sales Market Share by Type (2027–2032)
Table 54. Global Treatment Drug of Painful Diabetic Neuropathy Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Treatment Drug of Painful Diabetic Neuropathy Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Treatment Drug of Painful Diabetic Neuropathy Revenue Market Share by Type (2021–2026)
Table 57. Global Treatment Drug of Painful Diabetic Neuropathy Revenue Market Share by Type (2027–2032)
Table 58. Global Treatment Drug of Painful Diabetic Neuropathy Price (US$/Dose) by Type (2021–2026)
Table 59. Global Treatment Drug of Painful Diabetic Neuropathy Price (US$/Dose) by Type (2027–2032)
Table 60. Global Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose) by Application (2021–2026)
Table 61. Global Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose) by Application (2027–2032)
Table 62. Global Treatment Drug of Painful Diabetic Neuropathy Sales Market Share by Application (2021–2026)
Table 63. Global Treatment Drug of Painful Diabetic Neuropathy Sales Market Share by Application (2027–2032)
Table 64. Global Treatment Drug of Painful Diabetic Neuropathy Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Treatment Drug of Painful Diabetic Neuropathy Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Treatment Drug of Painful Diabetic Neuropathy Revenue Market Share by Application (2021–2026)
Table 67. Global Treatment Drug of Painful Diabetic Neuropathy Revenue Market Share by Application (2027–2032)
Table 68. Global Treatment Drug of Painful Diabetic Neuropathy Price (US$/Dose) by Application (2021–2026)
Table 69. Global Treatment Drug of Painful Diabetic Neuropathy Price (US$/Dose) by Application (2027–2032)
Table 70. Abbott Laboratories Company Information
Table 71. Abbott Laboratories Description and Business Overview
Table 72. Abbott Laboratories Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Abbott Laboratories Treatment Drug of Painful Diabetic Neuropathy Product
Table 74. Abbott Laboratories Recent Developments/Updates
Table 75. Eli Lilly And Company Company Information
Table 76. Eli Lilly And Company Description and Business Overview
Table 77. Eli Lilly And Company Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Eli Lilly And Company Treatment Drug of Painful Diabetic Neuropathy Product
Table 79. Eli Lilly And Company Recent Developments/Updates
Table 80. Pfizer, Inc. Company Information
Table 81. Pfizer, Inc. Description and Business Overview
Table 82. Pfizer, Inc. Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Pfizer, Inc. Treatment Drug of Painful Diabetic Neuropathy Product
Table 84. Pfizer, Inc. Recent Developments/Updates
Table 85. Lupin Limited Company Information
Table 86. Lupin Limited Description and Business Overview
Table 87. Lupin Limited Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Lupin Limited Treatment Drug of Painful Diabetic Neuropathy Product
Table 89. Lupin Limited Recent Developments/Updates
Table 90. Astellas Pharma, Inc. Company Information
Table 91. Astellas Pharma, Inc. Description and Business Overview
Table 92. Astellas Pharma, Inc. Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Astellas Pharma, Inc. Treatment Drug of Painful Diabetic Neuropathy Product
Table 94. Astellas Pharma, Inc. Recent Developments/Updates
Table 95. Glenmark Pharmaceuticals Limited Company Information
Table 96. Glenmark Pharmaceuticals Limited Description and Business Overview
Table 97. Glenmark Pharmaceuticals Limited Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Glenmark Pharmaceuticals Limited Treatment Drug of Painful Diabetic Neuropathy Product
Table 99. Glenmark Pharmaceuticals Limited Recent Developments/Updates
Table 100. Boehringer Ingelheim International GmbH Company Information
Table 101. Boehringer Ingelheim International GmbH Description and Business Overview
Table 102. Boehringer Ingelheim International GmbH Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Boehringer Ingelheim International GmbH Treatment Drug of Painful Diabetic Neuropathy Product
Table 104. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 105. Novartis AG Company Information
Table 106. Novartis AG Description and Business Overview
Table 107. Novartis AG Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Novartis AG Treatment Drug of Painful Diabetic Neuropathy Product
Table 109. Novartis AG Recent Developments/Updates
Table 110. McKesson Corporation Company Information
Table 111. McKesson Corporation Description and Business Overview
Table 112. McKesson Corporation Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. McKesson Corporation Treatment Drug of Painful Diabetic Neuropathy Product
Table 114. McKesson Corporation Recent Developments/Updates
Table 115. GlaxoSmithKline PLC (GSK) Company Information
Table 116. GlaxoSmithKline PLC (GSK) Description and Business Overview
Table 117. GlaxoSmithKline PLC (GSK) Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. GlaxoSmithKline PLC (GSK) Treatment Drug of Painful Diabetic Neuropathy Product
Table 119. GlaxoSmithKline PLC (GSK) Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Treatment Drug of Painful Diabetic Neuropathy Distributors List
Table 123. Treatment Drug of Painful Diabetic Neuropathy Customers List
Table 124. Treatment Drug of Painful Diabetic Neuropathy Market Trends
Table 125. Treatment Drug of Painful Diabetic Neuropathy Market Drivers
Table 126. Treatment Drug of Painful Diabetic Neuropathy Market Challenges
Table 127. Treatment Drug of Painful Diabetic Neuropathy Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Treatment Drug of Painful Diabetic Neuropathy
Figure 2. Global Treatment Drug of Painful Diabetic Neuropathy Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Treatment Drug of Painful Diabetic Neuropathy Market Share by Type: 2025 & 2032
Figure 4. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Product Picture
Figure 5. Antidepressants Product Picture
Figure 6. Opioid Product Picture
Figure 7. Capsaicin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Treatment Drug of Painful Diabetic Neuropathy Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Treatment Drug of Painful Diabetic Neuropathy Market Share by Application: 2025 & 2032
Figure 11. Hospitals Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Others
Figure 14. Global Treatment Drug of Painful Diabetic Neuropathy Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Treatment Drug of Painful Diabetic Neuropathy Market Size (US$ Million), 2021–2032
Figure 16. Global Treatment Drug of Painful Diabetic Neuropathy Sales (K Dose), 2021–2032
Figure 17. Global Treatment Drug of Painful Diabetic Neuropathy Average Price (US$/Dose), 2021–2032
Figure 18. Treatment Drug of Painful Diabetic Neuropathy Report Years Considered
Figure 19. Treatment Drug of Painful Diabetic Neuropathy Sales Share by Manufacturers in 2025
Figure 20. Global Treatment Drug of Painful Diabetic Neuropathy Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Treatment Drug of Painful Diabetic Neuropathy Players: Market Share by Revenue in Treatment Drug of Painful Diabetic Neuropathy in 2025
Figure 22. Treatment Drug of Painful Diabetic Neuropathy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Treatment Drug of Painful Diabetic Neuropathy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Treatment Drug of Painful Diabetic Neuropathy Sales Market Share by Country (2021–2032)
Figure 25. North America Treatment Drug of Painful Diabetic Neuropathy Revenue Market Share by Country (2021–2032)
Figure 26. United States Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Treatment Drug of Painful Diabetic Neuropathy Sales Market Share by Country (2021–2032)
Figure 29. Europe Treatment Drug of Painful Diabetic Neuropathy Revenue Market Share by Country (2021–2032)
Figure 30. Germany Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Treatment Drug of Painful Diabetic Neuropathy Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Treatment Drug of Painful Diabetic Neuropathy Revenue Market Share by Region (2021–2032)
Figure 37. China Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Treatment Drug of Painful Diabetic Neuropathy Sales Market Share by Country (2021–2032)
Figure 45. Latin America Treatment Drug of Painful Diabetic Neuropathy Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Treatment Drug of Painful Diabetic Neuropathy Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Treatment Drug of Painful Diabetic Neuropathy Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Treatment Drug of Painful Diabetic Neuropathy Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Treatment Drug of Painful Diabetic Neuropathy by Type (2021–2032)
Figure 56. Global Revenue Market Share of Treatment Drug of Painful Diabetic Neuropathy by Type (2021–2032)
Figure 57. Global Treatment Drug of Painful Diabetic Neuropathy Price (US$/Dose) by Type (2021–2032)
Figure 58. Global Sales Market Share of Treatment Drug of Painful Diabetic Neuropathy by Application (2021–2032)
Figure 59. Global Revenue Market Share of Treatment Drug of Painful Diabetic Neuropathy by Application (2021–2032)
Figure 60. Global Treatment Drug of Painful Diabetic Neuropathy Price (US$/Dose) by Application (2021–2032)
Figure 61. Treatment Drug of Painful Diabetic Neuropathy Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
